Louise Woodhams, a CHIRI honours student (School of Pharmacy) [2016-current] in Dr Hani Al-Salami’s lab, has won a prestigious fund representing Australia (among 2 others from UQ and Griffith), to showcase her work entitled: “Novel nanotechnological advancement in new bile acid oral-targeted delivery for encapsulation of potential antidiabetic drugs”.  Louise presented her work in the IPF International Pharmaceutical World Congress in Taiwan (Aug 2017).

Louise competed against PhD students and researchers in pharmaceutical science and biotechnology, winning first place, which includes further funding to attend the upcoming International FIP World Congress of Pharmacy and Pharmaceutical Science in September 2017 being held in South Korea.

Louise’s recent successes have been complemented with her first paper (July 2017) on utilising bile acids in biotechnology and pharmaceutical delivery systems to treat Type 1 diabetes: Woodhams, L., and H. Al-Salami. 2017. “The roles of bile acids and applications of microencapsulation technology in treating Type 1 diabetes mellitus.” Therapeutic Delivery 8 (6): 401-409. https://www.ncbi.nlm.nih.gov/pubmed/28530150

Please congratulate Louise on this fantastic achievement.

Louise Woodhams                              Dr Hani Al-Salami